Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 35Small Cell Lung Carcinoma 13Triple Negative Breast Neoplasms 12Breast Neoplasms 9Ovarian Neoplasms 8Lung Neoplasms 7Endometrial Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Esophageal Neoplasms 4NSCLC 3Esophageal Squamous Cell Carcinoma 3Carcinoma 3Uterine Cervical Neoplasms 2Recurrence 2Neoplasms 2Mouth Neoplasms 2Laryngeal Neoplasms 2Fallopian Tube Neoplasms 2Brain Neoplasms 2Unresectable Locally Advanced or Metastatic Solid Tumors 1Thymoma 1Thymic epithelial tumor 1Stomach Neoplasms 1Stage III and IV Ovarian Cancer 1Squamous Non-small Cell Lung Cancer 1Squamous NSCLC 1Solid Tumor Cancer 1Solid Tumor 1Salivary Gland Malignant Neoplasms 1Respiratory Tract Neoplasms 1

Interventions

Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Hearing Loss × Carboplatin × Clear all
NCT05633719 2022-12-01

Multicenter, Prospective Observational Study for Early Diagnosis, and Development of Follow-up Protocol and Hearing Rehabilitation Program for Ototoxic Hearing Loss After Chemotherapy for Pediatric Solid Cancer

Seoul National University Hospital

Not yet recruiting
300 enrolled

Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡